Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness by Olliaro, P, Vaillant, M

Artemisinin and derivatives in the treatment of uncomplicated malaria. by White, N, Olliaro, P

Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. by White, N, Olliaro, P

Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis. by Zwang, J, Olliaro, P

The need for operational research and capacity-building in support of the Global Technical Strategy for Malaria 2016-2030 by Ramsay, A, Olliaro, P, Reeder, J

Sharing health research data - the role of funders in improving the impact by Terry, R, Littler, K, Olliaro, P

Monkeypox: how will we know if the treatments work? by Rojek, A, Dunning, J, Olliaro, P

Epidemic preparedness: why is there a need to accelerate the development of diagnostics? by Peeling, R, Murtagh, M, Olliaro, P

Chemoprophlaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations by Manoharan, L, Olliaro, P, Horby, P, Watson, C

Target product profiles for the diagnosis of Taenia solium taeniasis, neurocysticercosis and porcine cysticercosis by Donadeu, M, Fahrion, A, Olliaro, P, Abela-Ridder, B

The schistosomiasis clinical trials landscape: A systematic review of antischistosomal treatment efficacy studies and a case for sharing individual participant-level data (IPD) by Julé, A, Vaillant, M, Lang, T, Guérin, P, Olliaro, P

Eligibility criteria and outcome measures adopted in clinical trials of treatments of cutaneous leishmaniasis: systematic literature review covering the period 1991-2015 by López-Carvajal, L, Vélez, I, Arbeláez, M, Olliaro, P

Averting a malaria disaster - Reply by White, N, Nosten, F, Hien, T, Watkins, W, Olliaro, P

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. by Olliaro, P, Guerin, P, Gerstl, S, Haaskjold, A, Rottingen, J, Sundar, S

A comparison of Zika and dengue outbreaks using national surveillance data in the Dominican Republic. by Bowman, L, Rocklöv, J, Kroeger, A, Olliaro, P, Skewes, R

Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years by Olliaro, P, Kuesel, A, Halleux, C, Sullivan, M, Reeder, J

Microscopy for the detection, identification and quantification of malaria parasites on stained thick and thin blood films in research settings by Dhorda, M, Guerin, P, Baird, J, Carter, J, Olliaro, P

Time to reconsider the role of ribavirin in Lassa fever by Salam, AP, Cheng, V, Edwards, T, Olliaro, P, Sterne, J, Horby, P

A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. by Picot, S, Olliaro, P, de Monbrison, F, Bienvenu, A, Price, R, Ringwald, P

Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study by Osmanov, IM, Spiridonova, E, Bobkova, P, Carson, G, Sigfrid, L, Olliaro, P